Parto asistido vaginal con ventosa: Análisis, implementación y evaluación de un programa de formación

PCOS in Adolescent Girls and Young Women: Toward a Treatment Guided by Pathophysiology

Percepció del paciente oncohematològico i cuidador principal del risc de caigudes. MÀSTER ICO BADALONA

Percepció dels pares sobre el mètode cangur realitzat a la UCI Neonatal.

Percepción de la cultura de Seguridad de los pacientes en los dispositivos de salud mental. Comparativa entre dispositivos comunitarios y hospitalarios

Percepción del grado de seguridad de los pacientes hospitalizados en un hospital de la provincia de Girona de nivel 2B.

PeriOperative ISchemic Evaluation-3 (POISE-3) Trial. Ensayo Clínico que Evalúa la Isquemia Perioperatoria

PHASE 1/2 STUDY OF REGN5668 (MUC16 X CD28, A COSTIMULATORY BISPECIFIC) ADMINISTERED IN COMBINATION WITH CEMIPLIMAB OR REGN4018 (MUC16 X CD3)

Phase 3 Trial of Fianlimab (Regn3767, Anti-Lag-3) + Cemiplimab versus Pembrolizumab in patients with previously untreated unresectable locally advanced or metastatic Melanoma

Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF 302)

Phase 3, Randomized, Open-Label Study to Compare Ociperlimab (BGB-A1217) Plus Tislelizumab (BGB-A317) Plus Concurrent Chemoradiotherapy (cCRT) Followed by Ociperlimab Plus Tislelizumab or Tislelizumab Plus cCRT Followed by Tislelizumab Versus cCRT Followed by Durvalumab in Previously Untreated, Locally Advanced, Unresectable Non-Small Cell Lung Cancer

Phase Ib/II Multicentric Study Combining Glasdegib (PF-04449913) with temozolomide in patients with newly diagnosed Glioblastoma, safety and preliminary efficacy for the combination.

Phase II multicenter randomized trial to assess the efficacy and safety of first line nivolumab in combination with paclitaxel in subjects with R/M HNSCC unable for cisplatin-based chemotherapy

PHASE II RANDOMIZED, CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ABTL0812 IN COMBINATION WITH FOLFIRINOX FOR FIRST-LINE TREATMENT OF METASTATIC PANCREATIC CANCER

Phase II Study of Avelumab plus chemotherapy in the peri-operative treatment for patients with resectable Gastric cancer (GC) or Gastroesophageal Junction cancer (GEJC)

Phase IIb/III, Double-Blind, Randomised, Active-Controlled, Multi-Center, Non-Inferiority Clinical Trial, to assess the safety and immunogenicity of a booster vaccination with an adapted recombinant protein RBD fusion homodimer candidate (PHH-1V81) against SARS-CoV-2, in adults vaccinated against COVID-19

Phase III randomized sequential open-label study to evaluate the efficacy of FOLFOX + panitumumab followed by FOLFIRI + bevacizumab (Sequence 1) versus FOLFOX + bevacizumab followed by FOLFIRI + panitumumab (Sequence 2) in untreated patients with wild-type RAS metastatic, primary left-sided, unresectable colorectal cancer: The CR-SEQUENCE

phase III, randomized,open-label, multicenter study evaluating the efficacy and safety of adjuvant Giredestrant compared with physician’s choice of adjuvant endocrine monotherapy in patients with estrogen receptor-positive, HER2-negative early breast cancer

Plan de investigación de seguimiento poscomercialización (PMCF) para evaluar la seguridad y efectividad del dispositivo liberador de paclitaxel SEQUENT PLEASE NEO en pacientes con enfermedad arterial coronaria

PLATFORM Título del estudio: Plataforma de Ensayos Clínicos Adaptativos Aleatorizados en Enfermedad Crítica (PRACTICAL)